tirzepatide 65 units - 60mg FDA says compounding pharmacies can

For RA and T1D, given limited evidence from small-sample clinical studies or preclinical models, these interventions are currently in the exploratory stage and not recommended to replace conventional immunomodulators

Because subq isnt meant for that volume of fluid and IM is

The VEGFR2-Akt-eNOS angiogenic cascade increases blood vessel formation by 129-152% in preclinical studies

It can release hormones, inflammatory compounds, and other signaling substances that may contribute to insulin resistance, chronic inflammation, fatty liver disease, and elevated cardiovascular risk

DOMS,

When grouped by initial weight, both lower- and higher-weight subgroups showed significant weight regain, with no meaningful difference between them